Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

Literature DB >> 30030146

Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

Jonathan M Spergel¹, Evan S Dellon², Chris A Liacouras³, Ikuo Hirano⁴, Javier Molina-Infante⁵, Albert J Bredenoord⁶, Glenn T Furuta⁷.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Proton Pump Inhibitors

Year: 2018 PMID： 30030146 PMCID： PMC6139263 DOI： 10.1016/j.anai.2018.05.035

Source DB: PubMed Journal: Ann Allergy Asthma Immunol ISSN： 1081-1206 Impact factor: 6.347

× No keyword cloud information.

23 in total

1. Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis.

Authors: Alfredo J Lucendo; Ángel Arias; Jesús González-Cervera; José María Olalla; Javier Molina-Infante
Journal: J Allergy Clin Immunol Date: 2015-09-12 Impact factor: 10.793

2. Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis.

Authors: Jamie Sodikoff; Ikuo Hirano
Journal: J Allergy Clin Immunol Date: 2015-08-25 Impact factor: 10.793

3. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.

Authors: Ikuo Hirano; Nelson Moy; Michael G Heckman; Colleen S Thomas; Nirmala Gonsalves; Sami R Achem
Journal: Gut Date: 2012-05-22 Impact factor: 23.059

4. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.

Authors: Bram D van Rhijn; Pim W Weijenborg; Joanne Verheij; Marius A van den Bergh Weerman; Caroline Verseijden; René M J G J van den Wijngaard; Wouter J de Jonge; Andreas J P M Smout; Albert J Bredenoord
Journal: Clin Gastroenterol Hepatol Date: 2014-03-19 Impact factor: 11.382

Review 5. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Authors: Alfredo J Lucendo; Javier Molina-Infante; Ángel Arias; Ulrike von Arnim; Albert J Bredenoord; Christian Bussmann; Jorge Amil Dias; Mogens Bove; Jesús González-Cervera; Helen Larsson; Stephan Miehlke; Alexandra Papadopoulou; Joaquín Rodríguez-Sánchez; Alberto Ravelli; Jukka Ronkainen; Cecilio Santander; Alain M Schoepfer; Martin A Storr; Ingrid Terreehorst; Alex Straumann; Stephen E Attwood
Journal: United European Gastroenterol J Date: 2017-01-23 Impact factor: 4.623

6. Eosinophilic esophagitis versus proton pump inhibitor-responsive esophageal eosinophilia: Transcriptome analysis.

Authors: Tetsuo Shoda; Akio Matsuda; Ichiro Nomura; Naoko Okada; Kanami Orihara; Hironobu Mikami; Norihisa Ishimura; Shunji Ishihara; Kenji Matsumoto; Yoshikazu Kinoshita
Journal: J Allergy Clin Immunol Date: 2017-01-04 Impact factor: 10.793

Review 7. Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors: Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal: J Allergy Clin Immunol Date: 2011-04-07 Impact factor: 10.793

8. Proton pump inhibitor-responsive oesophageal eosinophilia: too early to change clinical practice.

Authors: Amanda B Muir; Mei-Lun Wang; David Metz; Gary Falk; Jonathan Markowitz; Jonathan M Spergel; Chris A Liacouras
Journal: Gut Date: 2016-07-26 Impact factor: 23.059

9. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors: Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal: Gut Date: 2012-05-12 Impact factor: 23.059

Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

1. Dual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis.

2. Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis.

3. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.

4. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.

Review 5. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

6. Eosinophilic esophagitis versus proton pump inhibitor-responsive esophageal eosinophilia: Transcriptome analysis.

Review 7. Eosinophilic esophagitis: updated consensus recommendations for children and adults.

8. Proton pump inhibitor-responsive oesophageal eosinophilia: too early to change clinical practice.

9. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

10. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.

1. Eosinophilic esophagitis and allergic comorbidities in a US-population-based study.

2. Immunology of the ancestral differences in eosinophilic esophagitis.

Review 3. Cost-effective care in eosinophilic esophagitis.

Review 4. Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

5. Minimally symptomatic patients with eosinophilic esophagitis should still be actively treated-PRO.

6. Medical algorithm: Diagnosis and treatment of eosinophilic esophagitis in children.

7. Validation of the Short-Form Esophageal Hypervigilance and Anxiety Scale.

8. Authors' response.

9. Recognising eosinophilic oesophagitis as a cause of food bolus obstruction.

10. The role of eosinophils in immunotherapy.